Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma

MLA

Katrin Rabold, et al. “Reprogramming of Myeloid Cells and Their Progenitors in Patients with Non-Medullary Thyroid Carcinoma.” Nature Communications, vol. 13, no. 1, Oct. 2022, pp. 1–14. EBSCOhost, https://doi.org/10.1038/s41467-022-33907-4.

APA

Katrin Rabold, Martijn Zoodsma, Inge Grondman, Yunus Kuijpers, Manita Bremmers, Martin Jaeger, Bowen Zhang, Willemijn Hobo, Han J. Bonenkamp, Johannes H. W. de Wilt, Marcel J. R. Janssen, Lenneke A. M. Cornelissen, Ilse C. H. van Engen-van Grunsven, Willem J. M. Mulder, Jan W. A. Smit, Gosse J. Adema, Mihai G. Netea, Yang Li, Cheng-Jian Xu, & Romana T. Netea-Maier. (2022). Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma. Nature Communications, 13(1), 1–14. https://doi.org/10.1038/s41467-022-33907-4

Chicago

Katrin Rabold, Martijn Zoodsma, Inge Grondman, Yunus Kuijpers, Manita Bremmers, Martin Jaeger, Bowen Zhang, et al. 2022. “Reprogramming of Myeloid Cells and Their Progenitors in Patients with Non-Medullary Thyroid Carcinoma.” Nature Communications 13 (1): 1–14. doi:10.1038/s41467-022-33907-4.